The Europe Pharmaceutical Drug Delivery Market would witness market growth of 3.7% CAGR during the forecast period (2023-2030).
Patient preferences and comfort play a crucial role in the adoption of drug delivery systems. As patients increasingly seek convenient and non-invasive methods of medication administration, pharmaceutical companies are investing in developing patient-friendly delivery options. Innovations such as wearable devices, oral films, and self-administration tools empower patients to take control of their treatment regimens, fostering adherence and improving overall health outcomes. The escalating incidence of chronic diseases, including cardiovascular disorders, respiratory conditions, and diabetes, has generated an increased demand for convenient and effective drug delivery systems.
Chronic conditions often require long-term medication, making patient-friendly delivery systems essential for successful treatment. Continuous glucose monitoring systems for diabetes management, for instance, integrate drug delivery with real-time monitoring, enhancing the overall patient experience. As per the World Health Organization (WHO), NCDs impact people in all age ranges in all countries and regions. 17 million fatalities from NCDs occur before the age of 70, even though these conditions are frequently associated with older age groups. Risk factors that contribute to noncommunicable diseases include hazardous diets, physical inactivity, tobacco smoke exposure, and the harmful use of alcohol and air pollution. Children, adults, and seniors are all susceptible to these conditions.
Elderly individuals in Europe often face a higher prevalence of chronic diseases such as cardiovascular diseases, diabetes, neurodegenerative disorders, and arthritis. Drug delivery innovations support personalized medicine approaches for seniors in Europe. Drug delivery methods are intended to be responsive to the needs of older persons in Europe, including easy-to-swallow formulations, liquid formulations, and alternate dosage forms that address age-related issues. Thus, all these factors will uplift the regional market’s expansion in the coming years.
The Germany market dominated the Europe Pharmaceutical Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $128.9 Billion by 2030. The UK market is exhibiting a CAGR of 2.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 4.5% during (2023 - 2030).
Free Valuable Insights: The Global Pharmaceutical Drug Delivery Market will Hit $1.9 Trillion by 2030, at a CAGR of 4.1%
Based on Route of Administration, the market is segmented into Injectable Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery, and Ocular Drug Delivery. Based on Application, the market is segmented into Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- F.Hoffmann-La Roche Ltd.
- Bayer AG
- Pfizer, Inc.
- Johnson & Johnson
- Novartis AG
- Amgen, Inc.
- Sanofi S.A.
- Cipla Limited
- Merck & Co., Inc.
Europe Pharmaceutical Drug Delivery Market Report Segmentation
By Route of Administration
- Injectable Drug Delivery
- Oral Drug Delivery
- Topical Drug Delivery
- Nasal Drug Delivery
- Ocular Drug Delivery
By Application
- Respiratory & Other Diseases
- Cancer
- Diabetes
- Cardiovascular Diseases
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pharmaceutical Drug Delivery Market, by Route of Administration
1.4.2 Europe Pharmaceutical Drug Delivery Market, by Application
1.4.3 Europe Pharmaceutical Drug Delivery Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.2.5 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2021-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2021, Aug – 2023, Oct) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Pharmaceutical Drug Delivery Market, by Route of Administration
5.1 Europe Injectable Drug Delivery Market, by Country
5.2 Europe Oral Drug Delivery Market, by Country
5.3 Europe Topical Drug Delivery Market, by Country
5.4 Europe Nasal Drug Delivery Market, by Country
5.5 Europe Ocular Drug Delivery Market, by Country
Chapter 6. Europe Pharmaceutical Drug Delivery Market, by Application
6.1 Europe Respiratory & Other Diseases Market, by Country
6.2 Europe Cancer Market, by Country
6.3 Europe Diabetes Market, by Country
6.4 Europe Cardiovascular Diseases Market, by Country
Chapter 7. Europe Pharmaceutical Drug Delivery Market, by Country
7.1 Germany Pharmaceutical Drug Delivery Market
7.1.1 Germany Pharmaceutical Drug Delivery Market, by Route of Administration
7.1.2 Germany Pharmaceutical Drug Delivery Market, by Application
7.2 UK Pharmaceutical Drug Delivery Market
7.2.1 UK Pharmaceutical Drug Delivery Market, by Route of Administration
7.2.2 UK Pharmaceutical Drug Delivery Market, by Application
7.3 France Pharmaceutical Drug Delivery Market
7.3.1 France Pharmaceutical Drug Delivery Market, by Route of Administration
7.3.2 France Pharmaceutical Drug Delivery Market, by Application
7.4 Russia Pharmaceutical Drug Delivery Market
7.4.1 Russia Pharmaceutical Drug Delivery Market, by Route of Administration
7.4.2 Russia Pharmaceutical Drug Delivery Market, by Application
7.5 Spain Pharmaceutical Drug Delivery Market
7.5.1 Spain Pharmaceutical Drug Delivery Market, by Route of Administration
7.5.2 Spain Pharmaceutical Drug Delivery Market, by Application
7.6 Italy Pharmaceutical Drug Delivery Market
7.6.1 Italy Pharmaceutical Drug Delivery Market, by Route of Administration
7.6.2 Italy Pharmaceutical Drug Delivery Market, by Application
7.7 Rest of Europe Pharmaceutical Drug Delivery Market
7.7.1 Rest of Europe Pharmaceutical Drug Delivery Market, by Route of Administration
7.7.2 Rest of Europe Pharmaceutical Drug Delivery Market, by Application
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Trials & Approvals:
8.2.6 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Johnson & Johnson
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental & Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Novartis AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 Cipla Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis
TABLE 1 Europe Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 2 Europe Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 3 Partnerships, Collaborations and Agreements– Pharmaceutical Drug Delivery Market
TABLE 4 Product Launches And Product Expansions– Pharmaceutical Drug Delivery Market
TABLE 5 Acquisition and Mergers– Pharmaceutical Drug Delivery Market
TABLE 6 Geographical expansions– Pharmaceutical Drug Delivery Market
TABLE 7 Trials & Approvals– Pharmaceutical Drug Delivery Market
TABLE 8 Europe Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 9 Europe Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 10 Europe Injectable Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 11 Europe Injectable Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 12 Europe Oral Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 13 Europe Oral Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 14 Europe Topical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 15 Europe Topical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 16 Europe Nasal Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 17 Europe Nasal Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 18 Europe Ocular Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 19 Europe Ocular Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 20 Europe Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 21 Europe Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 22 Europe Respiratory & Other Diseases Market, by Country, 2019 - 2022, USD Billion
TABLE 23 Europe Respiratory & Other Diseases Market, by Country, 2023 - 2030, USD Billion
TABLE 24 Europe Cancer Market, by Country, 2019 - 2022, USD Billion
TABLE 25 Europe Cancer Market, by Country, 2023 - 2030, USD Billion
TABLE 26 Europe Diabetes Market, by Country, 2019 - 2022, USD Billion
TABLE 27 Europe Diabetes Market, by Country, 2023 - 2030, USD Billion
TABLE 28 Europe Cardiovascular Diseases Market, by Country, 2019 - 2022, USD Billion
TABLE 29 Europe Cardiovascular Diseases Market, by Country, 2023 - 2030, USD Billion
TABLE 30 Europe Pharmaceutical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 31 Europe Pharmaceutical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 32 Germany Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 33 Germany Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 34 Germany Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 35 Germany Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 36 Germany Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 37 Germany Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 38 UK Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 39 UK Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 40 UK Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 41 UK Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 42 UK Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 43 UK Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 44 France Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 45 France Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 46 France Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 47 France Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 48 France Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 49 France Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 50 Russia Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 51 Russia Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 52 Russia Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 53 Russia Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 54 Russia Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 55 Russia Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 56 Spain Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 57 Spain Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 58 Spain Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 59 Spain Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 60 Spain Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 61 Spain Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 62 Italy Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 63 Italy Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 64 Italy Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 65 Italy Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 66 Italy Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 67 Italy Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 68 Rest of Europe Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 69 Rest of Europe Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 70 Rest of Europe Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 71 Rest of Europe Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 72 Rest of Europe Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 73 Rest of Europe Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 74 Key Information – GlaxoSmithKline PLC
TABLE 75 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 76 Key Information – Bayer AG
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Johnson & Johnson
TABLE 79 Key Information – Novartis AG
TABLE 80 Key Information – Amgen, Inc.
TABLE 81 Key Information – Sanofi S.A.
TABLE 82 Key Information – Cipla Limited
TABLE 83 Key Information - Merck & Co., Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Pharmaceutical Drug Delivery Market, 2019 - 2030, USD Billion
FIG 3 Key Factors Impacting Pharmaceutical Drug Delivery Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2021-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2021, Aug – 2023, Oct) Leading Players
FIG 7 Porter’s Five Forces Analysis - Pharmaceutical Drug Delivery Market
FIG 8 Europe Pharmaceutical Drug Delivery Market share, by Route of Administration, 2022
FIG 9 Europe Pharmaceutical Drug Delivery Market share, by Route of Administration, 2030
FIG 10 Europe Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2030, USD Billion
FIG 11 Europe Pharmaceutical Drug Delivery Market share, by Application, 2022
FIG 12 Europe Pharmaceutical Drug Delivery Market share, by Application, 2030
FIG 13 Europe Pharmaceutical Drug Delivery Market, by Application, 2019 - 2030, USD Billion
FIG 14 Europe Pharmaceutical Drug Delivery Market share, by Country, 2022
FIG 15 Europe Pharmaceutical Drug Delivery Market share, by Country, 2030
FIG 16 Europe Pharmaceutical Drug Delivery Market, by Country, 2019 - 2030, USD Billion
FIG 17 Recent strategies and developments: GlaxoSmithKline PLC (GSK)
FIG 18 SWOT Analysis: GlaxoSmithKline PLC
FIG 19 Recent strategies and developments: F. Hoffmann-La Roche Ltd
FIG 20 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 21 Recent strategies and developments: Bayer Ag
FIG 22 Swot Analysis: Bayer AG
FIG 23 SWOT Analysis: Pfizer, Inc.
FIG 24 Recent strategies and developments: Johnson & Johnson
FIG 25 SWOT Analysis: Johnson & Johnson
FIG 26 Recent strategies and developments: NOVARTIS AG
FIG 27 SWOT Analysis: Novartis AG
FIG 28 Swot Analysis: Amgen, Inc.
FIG 29 Recent strategies and developments: Sanofi S.a.
FIG 30 Swot Analysis: Sanofi S.A.
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Merck & Co., Inc.